NCT01457716

Pharmacokinetic Pilot Study on Budesonide/Formoterol

Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers, Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler: A Randomised, Open, Single Centre, Single Dose, Crossover Study in Healthy Subjects

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 17 (actual)
• Sponsor: Orion Corporation, Orion Pharma · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The aim of the study is to assess and compare the Pharmacokinetic (PK) of Budesonide and Formoterol after administration of 3 different product variants of Budesonide/Formoterol Easyhalers and Symbicort turbuhaler.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Budesonide	Single inhalation
DRUG	Formoterol	Single inhalation
DEVICE	Easyhaler	Inhaler device
DEVICE	Turbohaler Forte	Inhaler device

Timeline

• Start date: 2011-10-01
• Primary completion: 2011-11-01
• Completion: 2011-12-01
• First posted: 2011-10-24
• Last updated: 2012-02-03

Locations

1 site across 1 country: Germany